President Richard Nixon passed the Controlled Substances Act, which placed all psychedelic drugs into Schedule I.
"Nixon passed the Controlled Substances Act, which is the reason why all psychedelic drugs to this day are schedule one." (said at 0:15:12)
Under the Nixon administration, the Comprehensive Drug Abuse Prevention and Control Act of 1970 established the Controlled Substances Act (CSA), which categorized classic serotonergic psychedelics (including LSD, psilocybin, DMT, and mescaline) into Schedule I—the most restrictive tier, defined as having a high potential for abuse and no accepted medical use in treatment. These classic psychedelics largely remain in Schedule I today. However, the claim that 'all psychedelic drugs' are in Schedule I requires qualification: certain non-classic psychedelic or dissociative compounds utilized in psychedelic-assisted therapy, such as ketamine, are classified under Schedule III, and other naturally occurring substances with psychedelic properties (such as Salvia divinorum) are not scheduled under federal law.
- supports: Psychedelics: Where we are now, why we got here, what we must do (Neuropharmacology 2018)
"This was followed by its abuse and stigmatization in the 1960s that ultimately led to the placement of LSD and other psychedelic drugs into the most restrictively regulated drug schedule of the United States Controlled Substances Act (Schedule I) in 1970 and its international counterparts." (abstract, passage verified)
openalexfull study (doi) - context: Classic and non‐classic psychedelics for substance use disorder: A review of their histori… (Addiction Neuroscience 2022)
"In this non-systematic review we discuss past and current clinical and observational studies with classic (LSD, DMT, psilocybin and mescaline) and non-classic (ibogaine, ketamine, MDMA, salvinorin A and THC) psychedelics for the treatment of SUD published until December 2021." (abstract, passage verified)
openalexfull study (doi)